Health Condition 1: C23- Malignant neoplasm of gallbladder
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients with radiologically or histologically suspected gall bladder cancer upto stage IIIB undergoing extended cholecystectomy or completion extended cholecystectomy
Exclusion criteria
Exclusion criteria: Patients with disease stage IVA or IVB Patients with distant metastasis Patients unfit for surgery Patients undergoing only palliative procedures Pregnancy at time of surgery History of prior major hepatic resection
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare lymph node yield between open and laparoscopic extended cholecystectomy for gall bladder cancer.Timepoint: March 2026 - June 2027 | — |
Secondary
| Measure | Time frame |
|---|---|
| To compare postoperative quality of life using validated instruments 1. QoR-15 on POD 2 2. EQ-5D at 1 monthTimepoint: Baseline, 2 days, 1 month;To compare intraoperative parameters 1. operative time 2. blood lossTimepoint: 1 day;To compare postoperative complicationsTimepoint: 1 month;To compare staging on histopathology.Timepoint: 3 weeks;To observe factors leading to conversion of laparoscopic into open procedure.Timepoint: 1 day;To compare duration of postoperative hospital stayTimepoint: 1 month | — |
Countries
India
Contacts
Post Graduate Institute of Medical Education and Research